HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea

Clinical and Experimental Rheumatology

Volumn 19, Issue 5 SUPPL. 24, 2001, Pages

  Chang, H K ^a   Kim, J U ^a   Cheon, K S ^a   Chung, H R ^a   Lee, K W ^b   Lee, I H ^c  

^a University of Ulsan   (South Korea)

^b Hallym University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Allelic types of HLA B51; Beh et's disease; HLA B51 antigen; Nested PCR SSP

Indexed keywords

HLA B ANTIGEN; HLA B ANTIGENS; HLA BW51; HLA-BW51;

ADULT; ALLELE; APHTHOUS STOMATITIS; ARTICLE; BEHCET DISEASE; CASE CONTROL STUDY; DNA SEQUENCE; ERYTHEMA NODOSUM; FEMALE; GENETICS; HUMAN; KOREA; MALE; METHODOLOGY; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; UVEITIS;

ADULT; ALLELES; BEHCET SYNDROME; CASE-CONTROL STUDIES; ERYTHEMA NODOSUM; FEMALE; HLA-B ANTIGENS; HUMAN; KOREA; MALE; MIDDLE AGE; POLYMERASE CHAIN REACTION; RECURRENCE; SEQUENCE ANALYSIS, DNA; STOMATITIS, APHTHOUS; SUPPORT, NON-U.S. GOV'T; UVEITIS;

EID: 18844465231     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. MIZUKI N, IONOKO H, OHNO S: Pathogenesis gene responsible for the predisposition to the Behçet's disease. Int Rev Immunol 1997; 14: 33-48.
2. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-91.
3. KAKLAMANI VG, VAIOPOULOS G, KAKLAMANIS PG: Behçet's disease. Semin Arthritis Rheum 1998; 27: 197-217.
4. YAZICI H, TUZUN Y, PAZARLI H, YALCIN B, YURDAKUL S, MUFTUOGLU A: The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 1980; 7: 206-10.
5. YAZICI H, AKOKAN G, YALCIN B, MUFTUOGLU A: The high prevalence of HLA-B5 in Behçet's disease. Clin Exp Immunol 1977; 30: 259-61.
6. AL-RAWI ZS, SHARQUIE KE, KHALIFA SJ, ALHADITHI FM, MUNIR JJ: Behçet's disease in Iraqi patients. Ann Rheum Dis 1986; 45: 987-90.
7. KOUMANTAKI Y, STAVROPOULOS C, SPYROPOULOU M, MESSINI H, PAPADEMETROPOULOS M, GIZIAKI E, et al.: HLA-B*5101 in Greek patients with Behçet's disease. Hum Immunol 1998; 59: 250-5.
8. KERA J, MIZUKI N, OTA M, et al.: Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients. Tissue Antigens 1999; 54: 565-71.
9. GONZÁLEZ-ESCRIBANO MF, RODRÍGUEZ MR, WALTER K, SANCHEZ-ROMAN J, GARCÍA-LOZANO JR, NÚÑEZ-ROLDÁN A: Association of HLA-B51 subtypes and Behçet's disease in Spain. Tissue Antigens 1998; 52: 78-80.
10. CHUNG YM, TSAI ST, LIAO F, LIU JH: A genetic study of Behçet's disease in Taiwan Chinese. Tissue Antigens 1987; 30: 68-72.
11. OHNO S, OHGUCHI M, HIROSI S, MATSUDA H, WAKISAKA A, AIZAWA M: Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982; 100: 1455-8.
12. MIZUKI N, INOKO H, ANDO H, NAKAMURA S, KASHIWASE K, AKAZA T, et al.: Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol 1993; 116: 406-9.
13. LEE S, KOH YJ, KIM OH, BANG D, NAM IW, LEE KH, et al.: A study of HLA antigens in Behçet's syndrome. Yonsei Med J 1988; 29: 259-62.
14. VERITY DH, MARR JE, OHNO S, WALLACE GR, STANFORD MR: Behçet's disease, the silk road and HLA-B51: Historical and geographical perspectives. Tissue Antigens 1999; 54: 213-20.
15. MIZUKI N, OTA M, KATSUYAMA Y, YABUKI K, ANDO H, GOTO K, et al.: Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum 1999; 42: 1961-6.
16. WALLACE GR, VERITY DH, DELAMAINE LJ, OHNO S, INOKO H, OTA M, et al.: MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics 1999; 49: 613-7.
17. GEORGE DL, WIENER SG: Skin and rheumatic disease. In: KLIPPE JH, DIEPPE PA (Eds.): Rheumatology. London, Mosby 1998: 2.5.1-2.5.12.
18. MIZUSHIMA Y: Recent research into Behçet's disease in Japan. Int J Tissue React 1988; 10: 59-65.
19. ®100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991; 10: 506-13.
20. HEIN J, BÖTTCHER K, GRUNDMANN R, KIRCHNER H, BEIN G: Low resolution DNA typing of the HLA-B5 cross-reactive group by nested PCR-SSP. Tissue Antigens 1995; 45: 27-35.
21. STEINER N, NG J, BUSH J, HARTZMAN RJ, JOHNSTON-DOW L, HURLEY CK: HLA-B alleles associated with the B15 serologically defined antigens. Hum Immunol 1997; 56: 84-93.
22. VALENTE RM, HALL S, O'DUFFY JD, CONN DL: Vasculitis and related disorders. In KELLEY WN, HARRIS ED, RUDDY S, SLEDGE CB (Eds.): Textbook of Rheumatology. Philadelphia, W.B. Saunders 1997: 1079-122.
23. ZOUBOULIS CC, DJAWARI D, KIRCH W, KEITEL W, OCHSENDORF F, ORFANOS CE: Adamantiades- Behçet's disease in Germany. In GODEAU P, WECHSLER B (Eds.): Behçet's Disease. New York, Elsevier Science 1993: 193-6.
24. ZOUBOULIS CC, KOTTER I, DJAWARI D, KIRCH W, KOHL PK, OCHSENDORF FR: Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-22.
25. BANG D, YOON KH, CHUNG HG, CHOI EH, LEE ES, LEE S: Epidemiological and clinical features in Behçet's disease in Korea. Yonsei Med J 1997; 38: 428-36.
26. INABA G: Clinical features of neuro-Behçet's syndrome. In: LEHNER T, BARNES CG (Eds.): Recent Advances in Behçet's Disease. London, Royal Society of Medicine Services 1986: 235-46.
27. YURDAKUL S, GÜNAYDIN I, TÜZÜN Y, TANKURT N, PAZARLI H, ÖZYAZGAN Y, et al.: The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol 1988; 15: 820-22.
28. LEHNER T, BATCHELOR JR: Classification and immunogenetic basis of Behçet's syndrome. In: LEHNER T, BARNES CG (Eds.): Behçet's Syndrome: Clinical and Immunological Features. New York, Academic Press 1979: 13-32.
29. KANEKO F, OYAMA N, NISHIBU A: Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997; 38: 444-54.
30. HASAN A, FORTUNE F, WILSON A, WARR K, SHINNICK T, MIZUSHIMA Y, et al.: Role of γδ T cells in the pathogenesis and diagnosis of Behçet's disease. Lancet 1996; 347: 789-94.
31. LEHNER T: The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 1997; 14: 21-32.
32. DIRESKENELI H, EKSIOGLU-DEMIRALP E, YAVUZ S, ERGUN T, SHINNICK T, LEHNER T, et al.: T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease. J Rheumatol 2000; 27: 708-13.
33. CORRELL RW, WESCOTT WB, JENSEN JL: Recurring, painful oral ulcers. J Am Dent Assoc 1981; 103: 497-8.
34. LEHNER T, BATCHELOR JR: Classification and an immunogenetic basis of Behçet's syndrome. In: LEHNER T, BARNES CG (Eds.): Behçet's Disease. Amsterdam, Exerpta Medica 1979: 13-32.
35. SHOHAT-ZABARSKI R, KALDERON S, KLEIN T, WEINBERGER A: Close association of HLA-B51 in persons with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1992; 74: 455-8.
36. ÖZBAKIR F, YAZICI H, MAT C, TÜZÜN Y, YURDAKUL S, YILMAZER S: HLA antigens in recurrent oral ulcerations: evidence against a common disease spectrum with Behçet's syndrome. Clin Exp Rheumatol 1987; 5: 263-5.
37. LIVNEH A, ZAKS N, KATZ J, LANGEVITZ P, SHEMER J, PRAS M: Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS). Clin Exp Rheumatol 1996; 14: 407-12.